Journal Information

Statistics

Follow this link to access the full text of the article

EFFICACY AND SAFETY OF ELRANATAMAB (PF-06863135), A B-CELL MATURATION ANTIGEN (BCMA)-CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
M Solha, NJ Bahlisb, NS Rajec, CL Costellod, B Dholariae, MY Levyf, MH Tomassong, H Dubeh, MA Damoreh, HK Lonh, C Basui, A Skouraj, EM Chank, S Trudell, A Jakubowiakm, MP Chun, C Gasparettoo, A Dalovisiop, M Sebagq, AM Lesokhinr
a Blood and Marrow Transplant Group of Georgia, Northside Hospital, Atlanta, United States
b Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Canada
c Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, United States
d Moores Cancer Center, University of California San Diego, La Jolla, United States
e Vanderbilt-Ingram Cancer Center, Nashville, United States
f Department of Medical Oncology, Baylor Scott and White Health, Dallas, United States
g Holden Comprehensive Cancer Center, University of Iowa, Iowa, United States
h Oncology Research and Development, Pfizer, San Diego, United States
i Early Clinical Development, Pfizer, San Diego, United States
j Oncology Research and Development, Pfizer, Pennsylvania, United States
k Oncology Research and Development, Pfizer, San Francisco, United States
l Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
m Department of Medicine, University of Chicago Medical Center, Chicago, United States
n Cross Cancer Institute, Edmonton, Canada
o Department of Medicine, Duke University Cancer Institute, Durham, United States
p Department of Hematology and Oncology, Ochsner Health, Jefferson, United States
q Cedars Cancer Center, McGill University Health Center, Montreal, Canada
r Division of Hematology and Oncology, Memorial Sloan Kettering Cancer Center/Weill Cornell Medical College, New York, United States
Ver más
Read
2731
Times
was read the article
1098
Total PDF
1633
Total HTML
Share statistics
Article information
ISSN: 25311379
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 May 37 10 47
2025 April 41 17 58
2025 March 64 19 83
2025 February 38 23 61
2025 January 38 26 64
2024 December 39 15 54
2024 November 41 30 71
2024 October 54 42 96
2024 September 36 19 55
2024 August 42 25 67
2024 July 31 18 49
2024 June 37 37 74
2024 May 39 35 74
2024 April 27 20 47
2024 March 38 25 63
2024 February 31 24 55
2024 January 22 14 36
2023 December 19 23 42
2023 November 44 32 76
2023 October 50 40 90
2023 September 49 26 75
2023 August 63 35 98
2023 July 71 20 91
2023 June 58 23 81
2023 May 65 31 96
2023 April 43 13 56
2023 March 47 34 81
2023 February 65 34 99
2023 January 64 36 100
2022 December 53 39 92
2022 November 77 36 113
2022 October 41 34 75
2022 September 34 30 64
2022 August 13 17 30
2022 July 17 26 43
2022 June 16 24 40
2022 May 14 25 39
2022 April 9 21 30
2022 March 16 18 34
2022 February 11 16 27
2022 January 10 16 26
2021 December 13 13 26
2021 November 11 25 36
2021 October 5 12 17
Show all

Follow this link to access the full text of the article

Idiomas
Hematology, Transfusion and Cell Therapy